Texas Diabetes and Endocrinology
Austin, Texas 78749
3 studies enrolling now · 29 studies all time
What they study most
Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Growth Hormone Deficiency With Pituitary Anomalies, Obesity, Overweight, Primary Hypertension, Type 1 Diabetes, Type 1 Diabetes Mellitus
Studies at this site
- OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events — Recruiting now
- A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight — Recruiting now
- Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes — Recruiting now
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight — Completed
- In-Home Study With MiniMed™ 780G Pump Automated Control in Type 2-Evaluation of the AHCL System in Adults With Insulin-requiring Type 2 Diabetes — Completed
- A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight — Completed
- Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial — Running, not enrolling
- A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD) — Completed
- OP5-005 Using Omnipod 5 in Adults With Type 2 — Completed
- Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes — Completed
- Eversense® Non-adjunctive Use Post Approval Study — Running, not enrolling
- Post Approval Study of the Eversense® Continuous Glucose Monitoring — Completed
- SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes — Withdrawn before enrolling
- Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes — Completed
- Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial — Completed
- Use of the Guardian™ Connect System With Smart Connected Devices — Completed
- Control-IQ Technology in Individuals With Type 2 Diabetes — Completed
- Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes — Stopped early
- Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics — Completed
- A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes — Completed
- A Study of LY3209590 in Participants With Type 2 Diabetes Mellitus — Completed
- A Study of LY2623091 in Participants With High Blood Pressure — Completed
- A Study of LY900014 in Participants With Type 1 Diabetes — Completed
- A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes — Completed
- Comparison of Hepatic Directed Vesicle (HDV)-Insulin Lispro Versus Insulin Lispro to Further Improve Glycemic Control — Completed
- Validation of Macimorelin as a Test for Adult Growth Hormone Deficiency — Completed
- A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) — Completed
- Safety Study of Subcutaneously-Injected Prandial INSULIN-PH20 NP Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes Mellitus — Completed
- Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus — Completed